The present invention relates to a method for the diagnosis of prostate cancer, especially in the diagnosis of diseases of the following methods: self-LG, i.e., a good prognosis of the primary tumor; HG, i.e., poor prognosis of individuals; PrCa Met, i.e., poor prognosis and ...
目的:前列腺癌(Prostate Cancer,PCa)是威胁男性健康最常见的肿瘤之一,近年来,前列腺癌在我国的发病率明显上升,目前已经成为所有恶性肿瘤中发病率增速最快的病种。由于... 许晓平,张建平,何思敏,... - 全国放射性药物与标记化合物学术交流会 被引量: 0发表: 2014年 靶向PSMA的前列腺癌超顺磁性分子探针的设计,合成...
The present invention also provides a method to aid in the diagnosis of benign prostatic hyperplasia or prostate cancer, the following: the detection and b) said marker comprises the steps of: detecting a protein at least one marker in a sample a) from the subject , the method comprising ...
摘要: This invention provides cDNA encoding a prostate-cancer specific marker, Repro-PC-1.0, Repro-PC-1.0 polypeptides and methods for use in diagnosis and therapy.收藏 引用 批量引用 报错 分享 文库来源 其他来源 求助全文 Prostate cancer-specific marker 优质文献 ...
PROSTATE CANCER-SPECIFIC MARKER 专利内容由知识产权出版社提供 专利名称:PROSTATE CANCER-SPECIFIC MARKER 发明人:FRENCH, Cynthia, K.,SCHNEIDER, Patrick, A.,YAMAMOTO, Karen, K. 申请号:EP98910225.6 申请日:19980306 公开号:EP 0981614 A1 公开日:20000301 摘要:This invention provides cDNA encoding a ...
An SLC18A2 gene serves as a marker of prostate cancer. Methods are provided for diagnosing prostate cancer, predicting or prognosticating the disease outcome, predicting recurrence following surgery, and monitoring disease progression in an individual having prostate cancer. The methods relate to ...
An SLC18A2 gene serves as a marker of prostate cancer. Methods are provided for diagnosing prostate cancer, predicting or prognosticating the disease outcome, predicting recurrence following surgery, and monitoring disease progression in an individual having prostate cancer. The methods relate to ...
Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men . Cancer Res . 2003; 63... K Woodson...
MARKER GENES FOR PROSTATE CANCER CLASSIFICATIONThe present invention relates to a method for classifying a prostate cancer in a subject, the method comprising the steps of a) determining a gene expression level or gene expression pattern of the genes F3 and IGFBP3 in a sample from the subject ...
PROSTATE CANCER TUMOR MARKER 优质文献 相似文献DETERMINATION OF CANCER ANTIGEN CA15-3 AND ALPHA FETO PROTEIN (AFP) LEVELS AS TUMOR MARKER IN PATIENTS WITH BREAST AND PROSTATE CANCER DETERMINATION OF CANCER ANTIGEN CA15-3 AND ALPHA FETO PROTEIN (AFP) LEVELS AS TUMOR MARKER IN PATIENTS WITH BREAST...